Kaidre Bendjama, Transgene, Strasborg, France, considers the potential of oncolytic viruses such as TG6002 in the management of gastrointestinal malignancies, including targeting patients with liver metastases by injecting the virus directly into the hepatic artery, as well as the potential of this novel approach in other solid tumor types, including sarcomas. This interview took place at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021.
